The general General Anesthesia Drugs Market is anticipated to reach a value of US$ 4.7 billion by the end of 2022 and to grow at a CAGR of 3.4% to US$ 6.7 billion by 2032. Propofol is the most popular drug class right now, with a market share of about 25.6% in 2021, according to …
Category Archives: Healthcare Trends
Medical Germicidal Lamps Market is projected to grow at a CAGR of 9.1% through 2032
The medical germicidal Lamps market is expected to be worth US$ 560.5 million by 2032, up from US$ 215.8 million in 2022, with a 9.1% CAGR from 2022 to 2032. Medical germicidal lamps are in high demand due to an increase in surgeries and a growing desire for better healthcare facilities. New technologies such as …
Phakic Intraocular Lenses Market is expected to reach US$ 819.5 Million by 2032
As per Future Market Insights’ latest analysis, the global phakic intraocular lenses (IOL) market reached US$ 344.4 Million in 2021. Sales are projected to grow at a 9.5% CAGR over the forecast period, with the market valuation reaching US$ 819.5 Million in 2032. Patients with high ametropia or contraindications to laser refractive surgery are treated with phakic intraocular …
Continue reading “Phakic Intraocular Lenses Market is expected to reach US$ 819.5 Million by 2032”
Multi-Channel Remote ECG Monitors Market is likely to accumulate a CAGR of 4.8% through 2032
The global multi-channel remote ECG monitors market is expected to be valued at US$ 314.7 million by 2032, up from US$ 187.8 million in 2022, at a CAGR of 4.8% during the forecast period. Increasing rate of heart disease is a worldwide problem which resulted in an increase in mortality rate of human and also some physicals dysfunction. Researcher consistently focusing on innovative …
Keyhole Orthopaedic Surgery Market is expected to rise at 6% to 7% value CAGR by 2032
By the end of 2032, the global keyhole orthopaedic surgery industry is estimated to earn more than $8 billion in incremental revenue. The keyhole orthopaedic surgery market is expected to approach US$ 5.5 billion by 2022, with a CAGR of 6% to 7% between 2022 and 2032. Keyhole orthopaedic surgery is a minimally invasive treatment …
North America is expected to be the most opportunistic Live Cell RNA Detection market, expanding at a 35.0% share
Global Live Cell RNA Detection Market demand is anticipated to be valued at US$ 2,631.8 Million in 2022, forecast to grow at a CAGR of 8.4% to be valued at US$ 6,404.2 Million from 2022 to 2032. RNA plays an important role in cell and tissue development as well as disease progression thus it is …
Humanised Mouse Model Market Forecast to 2032 | By Axenis, Trans Genic, Genoway, Vitalstar Biotechnology
In 2022, the global humanised mouse model market is anticipated to be worth US$ 92.5 million. Throughout the decade 2022 to 2032, the industry is expected to grow at a 5.5% CAGR to reach US$ 167.3 Million. Rising healthcare industry need for more active screening of innovative drug candidates identified to cure a variety of …
Oxygen Therapy Equipment Market is expected to reach a valuation of US$ 6.4 Billion by 2032 | FMI Study
The Oxygen Therapy Equipment Market is projected to grow at a CAGR of 7.4% between 2022 and 2032. From US$ 3.1 billion in 2022, the market for oxygen therapy equipment is projected to grow to US$ 6.4 billion in 2032. “Over the forecast period, the demand is expected to be driven by the rising popularity …
Veterinary Molecular Diagnostics Market totaling around US$ 352.8 Million by 2032
[275 Page Document] In 2022, the market for veterinary molecular diagnostics is projected to be worth US$182.1 million. The overall demand for veterinary molecular diagnostics is anticipated to increase at a CAGR of 6.84% between 2022 and 2032, reaching a total of about US$ 352.8 Million by 2032 due to the adoption of multiple testing …
Continue reading “Veterinary Molecular Diagnostics Market totaling around US$ 352.8 Million by 2032”
Next Generation Immunotherapies Market to expand at a 7.5% value CAGR by 2033
The global next generation immunotherapies market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, in order …
Continue reading “Next Generation Immunotherapies Market to expand at a 7.5% value CAGR by 2033”